Axsome Therapeutics (FRA:19X) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Axsome Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-04), Axsome Therapeutics's share price is €68.00. Axsome Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.86. Hence, Axsome Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Axsome Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:19X's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.44
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Axsome Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-1.04. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.86.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -14.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -31.80% per year.

During the past 11 years, Axsome Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -7.10% per year. The lowest was -105.50% per year. And the median was -25.00% per year.

Axsome Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Axsome Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Price-to-Operating-Cash-Flow Chart

Axsome Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Axsome Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Axsome Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Axsome Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Axsome Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Price-to-Operating-Cash-Flow falls into.

Axsome Therapeutics Price-to-Operating-Cash-Flow Calculation

Axsome Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	68.00	/	-3.861
	=

Axsome Therapeutics's Share Price of today is €68.00.
Axsome Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.86.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Axsome Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Axsome Therapeutics (FRA:19X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (FRA:19X) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

AXSM:USA 19X:Germany

Address

22 Cortlandt Street, 16th Floor, New York, NY, USA, 10007

Website

https://www.axsome.com

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

Axsome Therapeutics (FRA:19X) Headlines

No Headlines